<DOC>
	<DOCNO>NCT01172067</DOCNO>
	<brief_summary>The purpose study demonstrate QuickOpt optimization alternative method CRTP/D patient ' optimization clinical practice comparison improvement difference CRTP/D patient different optimization 12 month implantation.The hypothesis Heart Remolding parameter ( LVESV ) improvement patient use QuickOpt parameter 12 month implant inferior ( 10 % ) patient Echo optimization。</brief_summary>
	<brief_title>QuickOpt Chronic Study</brief_title>
	<detailed_description>Clinical study demonstrate AVTI QuickOptTM relate significantly max aorta VTI ( AVTI ) Echo , concordance correlation coefficient ( CCC ) high 0.96 0.99 . But , clinical trial evaluate mid-long term clinical outcome CRTP/D patient QuickOptTM Echo optimization , indeed main purpose study ; addition , clinical impact , status arrhythmia agent enrol patient , evaluate 1 year implant .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>• Patient meet current CRTP indication implant SJM CRTP device VV timing compatible lead system Patient able provide write informed consent study participation • Patient limit intrinsic atrial activity ( ≤ 40 bpm ) Patient persistent permanent AF Patient 2o 3o heart block Patient 's life expectancy &lt; 12 month Patient &lt; 18 year old Patient pregnant Patient IV inotropic agent Patients ongoing device agent study Patients heart transplant wait heart transplant Patients Hypertrophic obstructive cardiomyopathy Patients severe aortic valve mitral valve stenosis regurgitation without replacement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>CRT</keyword>
	<keyword>heart failure</keyword>
	<keyword>optimization</keyword>
	<keyword>Timing cycle optimization method</keyword>
</DOC>